Investigation Report on Chinese Imatinib Market, 2018-2022
SKU ID :CRI-11994621 | Published Date: 11-Jul-2018 | No. of pages: 30Description
TOC
Table of Contents
1 Basic Concepts of Imatinib
1.1 Indications for Imatinib
1.2 Development History of Imatinib in China
1.3 Governmental Approval of Imatinib in China
2 Sales of Imatinib in China, 2013-2017
2.1 Overall Sales of Imatinib
2.1.1 Sales Value
2.1.2 Sales Volume
2.2 Sales of Imatinib in Key Regions of China
2.2.1 Sales Value
2.2.2 Sales Volume
2.3 Sales of Imatinib by Dosage Form
2.4 Imatinib Smuggled to China
3 Analysis on Major Imatinib Manufacturers in China
3.1 Overview of Major Competitors
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Novartis
3.2.1 Enterprise Profile
3.2.2 Sales of Novartis's Imatinib (Gleevec) in China
3.3 Jiangsu Hansoh Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Hansoh Pharmaceutical's Imatinib (Xinwei) in China
3.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Chia Tai Tianqing Pharmaceutical's Imatinib (Genike) in China
3.5 CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
4 Prices of Imatinib in China, 2017-2018
4.1 Analysis on Average Price of Imatinib in China
4.1.1 Overall Price
4.1.2 Average Price by Region
4.2 Imatinib Price by Enterprise
4.2.1 Novartis (Gleevec)
4.2.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. (Xinwei)
4.2.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Genike)
4.2.4 CSPC Zhongqi Pharmaceutical Technology Co., Ltd.
5 Prospects of Chinese Imatinib Market, 2018-2022
5.1 Analysis on Factors Influencing Imatinib Development
5.1.1 Driving Forces
5.1.2 Unfavorable Factors
5.2 Forecast on Competition Pattern
5.3 Forecast on Market Size
Table of Charts
Chart Patents of Imatinib in China
Chart Governmental Approval of Imatinib in China
Chart Sales Value of Imatinib in China, 2013-2017
Chart Sales Value of Imatinib in Parts of China, 2013-2017
Chart Sales Volume of Imatinib in China, 2013-2017
Chart Market Share and Sales Value of Imatinib of Novartis (Switzerland) in China, 2013-2017
Chart Market Share and Sales Value of Hansoh Pharmaceutical's Imatinib in China, 2013-2017
Chart Market Share and Sales Value of Chia Tai Tianqing Pharmaceutical's Imatinib in China, 2013-2017
Chart Sales Value and Market Share of Imatinib Tablets in China, 2013-2017
Chart Sales Value and Market Share of Imatinib Capsules in China, 2013-2017
Chart Prices of Chia Tai Tianqing Pharmaceutical's Imatinib in Several Chinese Cities, 2017-2018
Chart Prices of Hansoh Pharmaceutical's Imatinib in Several Chinese Cities, 2017-2018
Chart Prices of Novartis's Imatinib (Gleevec) in Several Chinese Cities, 2017-2018
Chart Forecast on Sales Value of Imatinib in China, 2018-2012
Tables & Figures
Companies
Novartis
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- PRICE
-
$2200$3300